PARP Inhibitors May Soon Be Combined with Anti-VEGF, Chemotherapy, and Immunotherapy Agents

PARP Inhibitors May Soon Be Combined with Anti-VEGF, Chemotherapy, and Immunotherapy Agents

SGO2017

3 years
737 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Alexander B. Olawaiye, MD of Magee-Womens Hospital of UPMC discusses the use of PARP Inhibitors and in combination with Anti-VEGF, Chemotherapy, and Immunotherapy Agents. This was recorded at the 2017 Society of Gynecologic Oncology (SGO)s Annual Meeting on Womens Cancer® in National Harbor, MD.
Up Next Autoplay